EUCTR2010‐023871‐25‐GB.

Trial name or title	The FINOF (Femoral Nerve‐Block Intervention in Neck Of Femur Fracture) study ‐ FINOF
Methods	RCT Single‐blind
Participants	Inclusion criteria: ≥ 70 years of age, resident in own home or in warden‐aided flat, cognitively intact (as defined by a score ≥ 7 on the Abbreviated 10 point Mental Test Score (AMTS), prior fracture New Mobility Score ≥ 3, indicating independent indoor ambulation) Exclusion criteria: pre‐fracture hospitalization, contraindications to femoral nerve block analgesia, regular pre‐fracture opioid or glucocorticoid therapy, alcohol or substance abuse, morphine intolerance, postoperative surgical restrictions for ambulation
Interventions	Treatment group: femoral nerve block with ropivacaine 0.2% Control group: standard care
Outcomes	Primary endpoint(s): from day 1 to day 3 postoperatively: cumulative ambulation score, cumulative dynamic pain score postoperatively Secondary objective: to estimate the cost‐effectiveness of femoral nerve blockade vs usual care, to examine issues of compliance, acceptability to staff and participants
Starting date	20/04/2011
Contact information	Nottingham University Hospitals NHS Trust, United Kingdom; no contact provided
Notes